ATE330604T1 - Behandlung von manischen erkrankungen - Google Patents

Behandlung von manischen erkrankungen

Info

Publication number
ATE330604T1
ATE330604T1 AT97932764T AT97932764T ATE330604T1 AT E330604 T1 ATE330604 T1 AT E330604T1 AT 97932764 T AT97932764 T AT 97932764T AT 97932764 T AT97932764 T AT 97932764T AT E330604 T1 ATE330604 T1 AT E330604T1
Authority
AT
Austria
Prior art keywords
treatment
manic
diseases
manic diseases
relates
Prior art date
Application number
AT97932764T
Other languages
English (en)
Inventor
Anders Fink-Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE330604T1 publication Critical patent/ATE330604T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
AT97932764T 1996-07-31 1997-07-25 Behandlung von manischen erkrankungen ATE330604T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK82496 1996-07-31

Publications (1)

Publication Number Publication Date
ATE330604T1 true ATE330604T1 (de) 2006-07-15

Family

ID=8097971

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97932764T ATE330604T1 (de) 1996-07-31 1997-07-25 Behandlung von manischen erkrankungen

Country Status (18)

Country Link
US (1) US5914333A (de)
EP (1) EP0920316B1 (de)
JP (1) JP2000515156A (de)
KR (1) KR20000029525A (de)
CN (1) CN1226828A (de)
AT (1) ATE330604T1 (de)
AU (1) AU728191B2 (de)
BR (1) BR9710893A (de)
CA (1) CA2260863C (de)
CZ (1) CZ29899A3 (de)
DE (1) DE69736180T2 (de)
ES (1) ES2268732T3 (de)
HU (1) HUP9904030A3 (de)
IL (1) IL128028A0 (de)
NO (1) NO990450L (de)
PL (1) PL331321A1 (de)
WO (1) WO1998005330A1 (de)
ZA (1) ZA976854B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
ATE212550T1 (de) * 1997-08-01 2002-02-15 Elan Corp Plc Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
SK286669B6 (sk) * 1999-07-01 2009-03-05 Pharmacia & Upjohn Company Použitie opticky čistého (S,S)-reboxetínu alebo jeho farmaceuticky prijateľnej soli na výrobu lieku na liečenie alebo prevenciu periférnej neuropatie
US6270438B1 (en) * 1999-12-22 2001-08-07 Yuan-Cheng Liao Combination driving hub for bicycle
US20050070524A1 (en) * 2003-06-06 2005-03-31 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders
US20090139311A1 (en) 2007-10-05 2009-06-04 Applied Biosystems Inc. Biological Analysis Systems, Devices, and Methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5750140A (en) * 1994-05-20 1998-05-12 Novo Nordisk A/S Transdermal delivery of tiagabine
US5767117A (en) * 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
CZ292256B6 (cs) * 1995-05-05 2003-08-13 Novo Nordisk A/S Farmaceutická směs a způsob její přípravy
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
UA52661C2 (uk) * 1996-06-14 2003-01-15 Ново Нордіск А/С Безводна кристалічна форма гідрохлориду r(-)-n-(4,4-ди(3-метилтієн-2-іл)бут-3-еніл) ніпекотинової кислоти
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
DK174041B1 (da) * 1998-11-26 2002-05-06 Monarflex As Gennemføring til montering i en fleksibel membran

Also Published As

Publication number Publication date
HUP9904030A2 (hu) 2000-05-28
EP0920316B1 (de) 2006-06-21
DE69736180T2 (de) 2007-06-14
EP0920316A1 (de) 1999-06-09
CN1226828A (zh) 1999-08-25
JP2000515156A (ja) 2000-11-14
WO1998005330A1 (en) 1998-02-12
CZ29899A3 (cs) 1999-06-16
NO990450D0 (no) 1999-01-29
HUP9904030A3 (en) 2000-07-28
ZA976854B (en) 1998-03-19
DE69736180D1 (de) 2006-08-03
US5914333A (en) 1999-06-22
NO990450L (no) 1999-01-29
PL331321A1 (en) 1999-07-05
ES2268732T3 (es) 2007-03-16
CA2260863C (en) 2008-02-12
AU728191B2 (en) 2001-01-04
IL128028A0 (en) 1999-11-30
CA2260863A1 (en) 1998-02-12
AU3619797A (en) 1998-02-25
BR9710893A (pt) 1999-08-17
KR20000029525A (ko) 2000-05-25

Similar Documents

Publication Publication Date Title
PT841928E (pt) Formulacao de libertacao prolongada de d-trep-metilfenidato
ATE200863T1 (de) Indolinonverbindungen zur behandlung von krankheiten
DE60218493D1 (de) Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten
ATE231724T1 (de) Kombinationstherapie für die behandlung von psychosen
DE59608738D1 (de) Verwendung von epinastin für die behandlung von schmerzen
DE69536017D1 (de) Methoden und zusammensetzungen für die behandlung von glomerulonephritis
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE69927823T2 (de) Hydrogel für die therapeutische behandlung von aneurysmas
NO961483L (no) Fremgangsmåte for behandling av oljeholdig formasjon
DE69822665D1 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
DE69534908D1 (de) Verwendung von statin zur behandlung von hauterkrankungen
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
ATE330604T1 (de) Behandlung von manischen erkrankungen
DE69805305D1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
BR0012921A (pt) Compostos calcilìticos
DE69622889D1 (de) Substituierte 4-(1h-benzimidazol-2-yl)(1,4)diazepane für die behandlung von allergischen krankheiten
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
EE9700235A (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
DE60201440D1 (de) Aryl-8-azabicyclo[3.2.1]octanes für die behandlung von depression
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties